Quercetin exhibits neuroprotective effects in Alzheimer's disease (AD) by targeting P13 kinase, AKT/PKB tyrosine kinase, and protein kinase C. It enhances insulin sensitivity and glucose metabolism, suggesting its potential in diabetes treatment. The gene discussed is AKT1; the disease is early-onset autosomal dominant Alzheimer disease.